Ara-290 10MG

Product details

Ara-290

Product Name: Ara-290 (Cibinetide)

Molecular Formula: C87H138N24O25S2

Molecular Weight: ~1959.3 g/mol

Sequence: 11-amino acid peptide (derived from erythropoietin B-helix)

Purity: ≥98% (HPLC Verified)

Form: Lyophilized powder

Packaging: Sterile 2mg / 5mg vial

Storage: Store at -20°C. Protect from light and moisture.

Shelf Life: 24 months if properly stored

🔬 Product Overview:

Ara-290, also known as Cibinetide, is a synthetic peptide derived from a specific region of erythropoietin (EPO) that retains tissue-protective properties without stimulating erythropoiesis. It has been extensively studied in preclinical and clinical settings for its neuroprotective, anti-inflammatory, and tissue repair effects.

Research indicates that Ara-290 interacts with the innate repair receptor (IRR), activating pathways associated with immune modulation, neuroprotection, and vascular repair. These unique properties make Ara-290 a valuable tool in research involving neuropathy, tissue damage, and inflammatory conditions.

High Purity Research Peptide

Technical Specifications

Product Description

Ara-290 (Cibinetide) is an erythropoietin-derived peptide fragment designed to selectively engage the innate repair receptor (IRR). Unlike full-length EPO, Ara-290 does not increase red blood cell production, making it more suitable for research into non-erythropoietic therapeutic pathways.

In preclinical and clinical research, Ara-290 has demonstrated potential to:

• Reduce neuropathic pain and inflammation
• Support tissue regeneration and vascular health
• Provide neuroprotection in models of nerve injury and ischemia
• Improve metabolic and immune regulation

Its unique mechanism of tissue protection without hematopoietic side effects makes Ara-290 an important research peptide for studies in neuroprotection, tissue healing, and chronic inflammatory disorders.

Precautions:

For research purposes only. Not approved for human or veterinary use. Handle with care in a controlled environment.